| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | Australia | 1 | |
| #3 | Canada | 1 | |
| #4 | EPO (European Patent Office) | 1 | |
| #5 | Israel | 1 | |
| #6 | Norway | 1 | |
| #7 | Russian Federation | 1 | |
| #8 | WIPO (World Intellectual Property Organization) | 1 | |
| #9 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | IT methods for management | |
| #4 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Measuring microorganism processes | |
| #4 | Data processing systems | |
| #5 | Unspecified technologies | |
| #6 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Remington Jack S | 14 |
| #2 | Araujo Fausto G | 13 |
| #3 | Prince Jeffrey B | 1 |
| #4 | De Araujo Fausto G | 1 |
| #5 | Sharma Somesh D | 1 |
| #6 | Tang Paul C | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2010097193A1 | Lifestyle management system and method | |
| US5686575A | Toxoplasma gondii P28 polypeptides | |
| AU6905094A | Use of rifamycin derivatives for the manufacture of a medicament for the treatment of toxoplasmosis | |
| US5529994A | Treatment for toxoplasmosis |